Transworld Shipping Lines Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: September 28, 2025, 11:37 pm

Quick Insight

Transworld Shipping Lines Ltd currently trades at ₹263 with a market capitalization of ₹579 Cr and a price-to-earnings ratio of 15.5. The company's return on equity stands at 5.71%, while its return on capital employed is 6.83%. With an operating profit margin of 19.37%, Transworld Shipping demonstrates operational efficiency compared to industry peers. However, the price-to-book value ratio of 0.68x suggests the stock may be undervalued relative to its asset base. The company's strong promoter holding of 70.43% provides stability and aligns interests with shareholders.

On the downside, Transworld Shipping's net profit of ₹34 Cr indicates room for improvement in profitability, possibly due to high borrowings of ₹332 Cr, impacting its interest coverage ratio of 5.24x. Additionally, the low institutional holding, with FIIs at 0.01% and DIIs not available, raises concerns about external investor confidence. Looking ahead, reducing debt levels and enhancing profitability through cost optimization could bolster the company's financial health and drive stock performance. Investors should monitor the company's efforts to improve profitability and reduce debt to assess its long-term sustainability and growth potential in the competitive shipping industry.

In conclusion, while Transworld Shipping Lines Ltd shows strengths in operational efficiency and promoter holding, the company faces risks related to profitability and high debt levels. Investors should closely watch the company's financial performance and strategic initiatives to gauge its ability to navigate industry challenges and deliver sustainable value in the long run.

Competitors of Transworld Shipping Lines Ltd

All Competitor Stocks of Transworld Shipping Lines Ltd

Quarterly Result

Last Updated: August 20, 2025, 3:40 am

Below is a detailed analysis of the quarterly data for Transworld Shipping Lines Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 94.89 Cr.. The value appears to be declining and may need further review. It has decreased from 110.62 Cr. (Mar 2025) to 94.89 Cr., marking a decrease of 15.73 Cr..
• For Expenses, as of Jun 2025, the value is 76.51 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 74.88 Cr. (Mar 2025) to 76.51 Cr., marking an increase of 1.63 Cr..
• For Operating Profit, as of Jun 2025, the value is 18.38 Cr.. The value appears to be declining and may need further review. It has decreased from 35.74 Cr. (Mar 2025) to 18.38 Cr., marking a decrease of 17.36 Cr..
• For OPM %, as of Jun 2025, the value is 19.37%. The value appears to be declining and may need further review. It has decreased from 32.31% (Mar 2025) to 19.37%, marking a decrease of 12.94%.
• For Other Income, as of Jun 2025, the value is 2.77 Cr.. The value appears strong and on an upward trend. It has increased from -11.57 Cr. (Mar 2025) to 2.77 Cr., marking an increase of 14.34 Cr..
• For Interest, as of Jun 2025, the value is 6.15 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 7.34 Cr. (Mar 2025) to 6.15 Cr., marking a decrease of 1.19 Cr..
• For Depreciation, as of Jun 2025, the value is 22.20 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 21.78 Cr. (Mar 2025) to 22.20 Cr., marking an increase of 0.42 Cr..
• For Profit before tax, as of Jun 2025, the value is -7.20 Cr.. The value appears to be declining and may need further review. It has decreased from -4.95 Cr. (Mar 2025) to -7.20 Cr., marking a decrease of 2.25 Cr..
• For Tax %, as of Jun 2025, the value is 8.47%. The value appears to be increasing, which may not be favorable. It has increased from -5.25% (Mar 2025) to 8.47%, marking an increase of 13.72%.
• For Net Profit, as of Jun 2025, the value is -7.81 Cr.. The value appears to be declining and may need further review. It has decreased from -4.69 Cr. (Mar 2025) to -7.81 Cr., marking a decrease of 3.12 Cr..
• For EPS in Rs, as of Jun 2025, the value is -3.56. The value appears to be declining and may need further review. It has decreased from -2.14 (Mar 2025) to -3.56, marking a decrease of 1.42.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: August 12, 2025, 2:53 pm

Growth

Last Updated: September 5, 2025, 1:31 pm

Balance Sheet

Last Updated: August 12, 2025, 2:53 pm

Below is a detailed analysis of the balance sheet data for Transworld Shipping Lines Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 22.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 22.00 Cr..
• For Reserves, as of Mar 2025, the value is 778.00 Cr.. The value appears strong and on an upward trend. It has increased from 745.00 Cr. (Mar 2024) to 778.00 Cr., marking an increase of 33.00 Cr..
• For Borrowings, as of Mar 2025, the value is 332.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 405.00 Cr. (Mar 2024) to 332.00 Cr., marking a decrease of 73.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 66.00 Cr.. The value appears to be improving (decreasing). It has decreased from 75.00 Cr. (Mar 2024) to 66.00 Cr., marking a decrease of 9.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 1,198.00 Cr.. The value appears to be improving (decreasing). It has decreased from 1,247.00 Cr. (Mar 2024) to 1,198.00 Cr., marking a decrease of 49.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 904.00 Cr.. The value appears to be declining and may need further review. It has decreased from 944.00 Cr. (Mar 2024) to 904.00 Cr., marking a decrease of 40.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 16.00 Cr.. The value appears to be declining and may need further review. It has decreased from 34.00 Cr. (Mar 2024) to 16.00 Cr., marking a decrease of 18.00 Cr..
• For Other Assets, as of Mar 2025, the value is 278.00 Cr.. The value appears strong and on an upward trend. It has increased from 269.00 Cr. (Mar 2024) to 278.00 Cr., marking an increase of 9.00 Cr..
• For Total Assets, as of Mar 2025, the value is 1,198.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,247.00 Cr. (Mar 2024) to 1,198.00 Cr., marking a decrease of 49.00 Cr..

Notably, the Reserves (778.00 Cr.) exceed the Borrowings (332.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Transworld Shipping Lines Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 15.44. This value is within the healthy range. It has increased from -23.23 (Mar 24) to 15.44, marking an increase of 38.67.
• For Diluted EPS (Rs.), as of Mar 25, the value is 15.44. This value is within the healthy range. It has increased from -23.23 (Mar 24) to 15.44, marking an increase of 38.67.
• For Cash EPS (Rs.), as of Mar 25, the value is 53.50. This value is within the healthy range. It has increased from 13.04 (Mar 24) to 53.50, marking an increase of 40.46.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 364.45. It has increased from 349.06 (Mar 24) to 364.45, marking an increase of 15.39.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 364.45. It has increased from 349.06 (Mar 24) to 364.45, marking an increase of 15.39.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 203.22. It has increased from 128.59 (Mar 24) to 203.22, marking an increase of 74.63.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 74.59. This value is within the healthy range. It has increased from 31.73 (Mar 24) to 74.59, marking an increase of 42.86.
• For PBIT / Share (Rs.), as of Mar 25, the value is 36.53. This value is within the healthy range. It has increased from -4.54 (Mar 24) to 36.53, marking an increase of 41.07.
• For PBT / Share (Rs.), as of Mar 25, the value is 16.19. This value is within the healthy range. It has increased from -21.65 (Mar 24) to 16.19, marking an increase of 37.84.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 15.43. This value is within the healthy range. It has increased from -23.23 (Mar 24) to 15.43, marking an increase of 38.66.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 15.44. This value is within the healthy range. It has increased from -23.23 (Mar 24) to 15.44, marking an increase of 38.67.
• For PBDIT Margin (%), as of Mar 25, the value is 36.70. This value is within the healthy range. It has increased from 24.67 (Mar 24) to 36.70, marking an increase of 12.03.
• For PBIT Margin (%), as of Mar 25, the value is 17.97. This value is within the healthy range. It has increased from -3.53 (Mar 24) to 17.97, marking an increase of 21.50.
• For PBT Margin (%), as of Mar 25, the value is 7.96. This value is below the healthy minimum of 10. It has increased from -16.83 (Mar 24) to 7.96, marking an increase of 24.79.
• For Net Profit Margin (%), as of Mar 25, the value is 7.59. This value is within the healthy range. It has increased from -18.06 (Mar 24) to 7.59, marking an increase of 25.65.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 7.59. This value is below the healthy minimum of 8. It has increased from -18.06 (Mar 24) to 7.59, marking an increase of 25.65.
• For Return on Networth / Equity (%), as of Mar 25, the value is 4.23. This value is below the healthy minimum of 15. It has increased from -6.65 (Mar 24) to 4.23, marking an increase of 10.88.
• For Return on Capital Employeed (%), as of Mar 25, the value is 7.55. This value is below the healthy minimum of 10. It has increased from -0.92 (Mar 24) to 7.55, marking an increase of 8.47.
• For Return On Assets (%), as of Mar 25, the value is 2.82. This value is below the healthy minimum of 5. It has increased from -4.09 (Mar 24) to 2.82, marking an increase of 6.91.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.31. This value is within the healthy range. It has decreased from 0.40 (Mar 24) to 0.31, marking a decrease of 0.09.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.41. This value is within the healthy range. It has decreased from 0.52 (Mar 24) to 0.41, marking a decrease of 0.11.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.36. It has increased from 0.21 (Mar 24) to 0.36, marking an increase of 0.15.
• For Current Ratio (X), as of Mar 25, the value is 1.60. This value is within the healthy range. It has increased from 1.32 (Mar 24) to 1.60, marking an increase of 0.28.
• For Quick Ratio (X), as of Mar 25, the value is 1.53. This value is within the healthy range. It has increased from 1.25 (Mar 24) to 1.53, marking an increase of 0.28.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 44.60. This value exceeds the healthy maximum of 8. It has increased from 5.04 (Mar 24) to 44.60, marking an increase of 39.56.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 14.04. This value is below the healthy minimum of 20. It has increased from -6.43 (Mar 24) to 14.04, marking an increase of 20.47.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 4.05. This value is below the healthy minimum of 20. It has decreased from 11.45 (Mar 24) to 4.05, marking a decrease of 7.40.
• For Earning Retention Ratio (%), as of Mar 25, the value is 85.96. This value exceeds the healthy maximum of 70. It has decreased from 106.43 (Mar 24) to 85.96, marking a decrease of 20.47.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 95.95. This value exceeds the healthy maximum of 70. It has increased from 88.55 (Mar 24) to 95.95, marking an increase of 7.40.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 5.24. This value is within the healthy range. It has increased from 1.87 (Mar 24) to 5.24, marking an increase of 3.37.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.51. This value is below the healthy minimum of 3. It has increased from -0.36 (Mar 24) to 2.51, marking an increase of 2.87.
• For Enterprise Value (Cr.), as of Mar 25, the value is 814.42. It has decreased from 957.22 (Mar 24) to 814.42, marking a decrease of 142.80.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.82. This value is within the healthy range. It has decreased from 3.39 (Mar 24) to 1.82, marking a decrease of 1.57.
• For EV / EBITDA (X), as of Mar 25, the value is 4.97. This value is below the healthy minimum of 5. It has decreased from 13.74 (Mar 24) to 4.97, marking a decrease of 8.77.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.23. This value is within the healthy range. It has decreased from 2.02 (Mar 24) to 1.23, marking a decrease of 0.79.
• For Retention Ratios (%), as of Mar 25, the value is 85.95. This value exceeds the healthy maximum of 70. It has decreased from 106.43 (Mar 24) to 85.95, marking a decrease of 20.48.
• For Price / BV (X), as of Mar 25, the value is 0.68. This value is below the healthy minimum of 1. It has decreased from 0.74 (Mar 24) to 0.68, marking a decrease of 0.06.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.23. This value is within the healthy range. It has decreased from 2.02 (Mar 24) to 1.23, marking a decrease of 0.79.
• For EarningsYield, as of Mar 25, the value is 0.06. This value is below the healthy minimum of 5. It has increased from -0.08 (Mar 24) to 0.06, marking an increase of 0.14.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness